Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The vitreo-retinal interface (VRI) is the anatomical and molecular boundary between the vitreous body and the retina. It consists of the inner limiting membrane (ILM) of the retina, the vitreous cortex, and an intervening extracellular matrix. Key components include collagen, laminin, fibronectin, Müller cells, and hyalocytes. It plays a crucial role in retinal adhesion, stability, and is implicated in various retinal diseases like PVD, macular holes, and retinal detachment.
N/A
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Vitreo-retinal Interface (VRI).